AU2022901688A0 - Pyran compounds and their use in the treatment of pain - Google Patents

Pyran compounds and their use in the treatment of pain

Info

Publication number
AU2022901688A0
AU2022901688A0 AU2022901688A AU2022901688A AU2022901688A0 AU 2022901688 A0 AU2022901688 A0 AU 2022901688A0 AU 2022901688 A AU2022901688 A AU 2022901688A AU 2022901688 A AU2022901688 A AU 2022901688A AU 2022901688 A0 AU2022901688 A0 AU 2022901688A0
Authority
AU
Australia
Prior art keywords
pain
treatment
pyran compounds
pyran
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901688A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vast Bioscience Pty Ltd
Original Assignee
Vast Bioscience Pty Ltd
Filing date
Publication date
Application filed by Vast Bioscience Pty Ltd filed Critical Vast Bioscience Pty Ltd
Publication of AU2022901688A0 publication Critical patent/AU2022901688A0/en
Pending legal-status Critical Current

Links

AU2022901688A 2022-06-21 Pyran compounds and their use in the treatment of pain Pending AU2022901688A0 (en)

Publications (1)

Publication Number Publication Date
AU2022901688A0 true AU2022901688A0 (en) 2022-07-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3684353A4 (en) Topical formulations of cannabinoids and use thereof in the treatment of pain
EP4090658A4 (en) Therapeutic agents and methods of treatment
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4126855C0 (en) Compounds and their use in the treatment of bacterial infections
GB202014736D0 (en) Novel compounds and their use in therapy
AU2023903833A0 (en) Pyran compounds and their use in the treatment of pain
AU2023903834A0 (en) Pyran compounds and their use in the treatment of pain
AU2022901694A0 (en) Pyran compounds and their use in the treatment of pain
AU2022901688A0 (en) Pyran compounds and their use in the treatment of pain
AU2021901286A0 (en) Pyran compounds and their use in the treatment of pain
AU2021901289A0 (en) Pyran compounds and their use in the treatment of pain
AU2020900245A0 (en) Pyran compounds and their use in the treatment of pain
AU2022299331A1 (en) Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders
IL290192A (en) Nitenin analogue compounds and their use in the treatment of chronic and acute pain
AU2019900258A0 (en) Pyran compounds and their use in the treatment of pain
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
EP4164619A4 (en) Treatment methods and formulations
EP3983535A4 (en) Stabilized mutants of quorum quenching lactonase and use thereof in treatment of pathogens
AU2021381054A9 (en) Pharmaceutical compositions for use in the management and treatment of pain
AU2021344801A9 (en) Specific cardiac tissue and the use thereof in the treatment of cardiac pathologies
AU2021904040A0 (en) Cannabidiol for the treatment of sciatica and other nerve pain
EP4046658A4 (en) Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases
EP4100395A4 (en) Quinazoline compounds and the use thereof in the treatment of cancer
AU2020902029A0 (en) Quinazoline compounds and the use thereof in the treatment of cancer
GB2610895C (en) Composition for use in the treatment and/or prevention of mycotoxic disease